richard lipton, md, director, montefiore headache center; edwin s. lowe professor and vice chairman of neurology, albert einstein college of medicine.
. the software identified and measured a marker of svd and then gave a score indicating how severe the disease was ranging from mild to severe.
.
.
kpcc in person
.
understanding cholesterol effects of adalimumab by new techniques was another goal of gelfand and mehta's study.
.
.